… is no known effective pharmaceutical treatment, although it is … regarding chloroquine for the
treatment of COVID-19. … the effectiveness of chloroquine for treatment of COVID-19 as well as …

… chloroquine and hydroxychloroquine for the treatment of COVID-19 by determining the
prevalence of COVID-19 … esis that these drugs could show efficacy in the treatment of COVID-19. …

… During Chloroquine treatment period, we observed 5 patients who experienced a total of
9 adverse events, including vomiting, abdominal pain, nausea, diarrhea, rash or itchy, cough, …

… agents against the new coronavirus SARS-CoV-2 that induces COVID-19 and as a possible
… treatment can induce oxidative stress and thus worsen the condition of COVID-19 patients. …

… treatment of HCQ and AZ for COVID-19 patients. Results showed that 81.3% of COVID-19 …
outcome and a shortened discharge time after a combination treatment of HCQ and AZ [15]. …

… to treat COVID-19. Among such drugs, hydroxychloroquine (HCQ) was one of the first drugs
to be tested for COVID-19 and has been recommended in national treatment guidelines in …

… In the early in vitro studies, chloroquine was found to block COVID-19 infection at low-… of
chloroquine or hydroxychloroquine in the treatment of COVID-19 associated pneumonia in more …

… No serious adverse events were observed in the chloroquine group… chloroquine in COVID-19
and suggests that chloroquine can be a cost-effective therapy for combating the COVID-19 …

… the role of chloroquine and hydroxychloroquine in … COVID-19. This systematic review aims
to summarize the available evidence regarding the role of chloroquine in treating coronavirus …

… treatment for COVID-19. Among the drugs under investigation, anti-malarials, chloroquine
(… current status of CQ/HCQ against SARS-CoV-2 and their use in the treatment of COVID-19. …